Ng is considered a promising biomarker able to detect synaptic dysfunction in AD patients because its CSF concentrations are increased in AD patients in comparison to healthy subjects and patients affected by other Neurodegenerative disorders (NDDs) [15]. Here, NRGN is linked to Alzheimer disease.